SCHEMBL4724944

SCHEMBL4724944

CC(CNC(=O)Cc1sc(-c2ccc(Cl)cc2)nc1-c1ccccc1)N1CCN(c2ncccn2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.52
MAPT P10636 3/20 0.52
MEN1 O00255 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
PTGDR2 Q9Y5Y4 13/20 0.52
KDM4E B2RXH2 6/20 0.52
ALDH1A1 P00352 4/20 0.52
HPGD P15428 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
NPSR1 Q6W5P4 2/20 0.45
POLB P06746 1/20 0.42
APOBEC3G Q9HC16 1/20 0.41
PPARG P37231 1/20 0.41
NCOA2 Q15596 1/20 0.41
NCOA1 Q15788 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4765488 1.00 KMT2A (0.52) KMT2AMAPTMEN1SMN1; SMN2PTGDR2
SCHEMBL4721901 0.95 KMT2A (0.49) KMT2AMAPTMEN1SMN1; SMN2PTGDR2
SCHEMBL9998826 0.84 MEN1 (0.52) KMT2AMAPTMEN1SMN1; SMN2PTGDR2
SCHEMBL4498016 0.84 MEN1 (0.52) KMT2AMAPTMEN1SMN1; SMN2PTGDR2
SCHEMBL9998261 0.78 MAPT (0.49) KMT2AMAPTNPSR1
SCHEMBL4766610 0.73 NR4A2 (0.54) KMT2AMEN1KDM4EHPGDCYP2C19
SCHEMBL12608913 0.72 KMT2A (0.65) KMT2AMAPTMEN1SMN1; SMN2PTGDR2
SCHEMBL12608906 0.71 PTGDR2 (0.81) KMT2AMAPTMEN1SMN1; SMN2PTGDR2
Fentiazac SCHEMBL16196751 0.70 PTGDR2 (1.00) KMT2AMAPTMEN1SMN1; SMN2PTGDR2
Fentiazac SCHEMBL24355 0.70 PTGDR2 (1.00) KMT2AMAPTMEN1SMN1; SMN2PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917262-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS P2X3 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2008-05-07 EP disclosed
WO-2007020194-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS P2X3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-02-22 WO disclosed